Funded Startups in Gothenburg
Disclosed round sizes in Gothenburg skew heavily toward a single outlier: Pagero’s $74M post-IPO debt round on 2022-05-09, which dwarfs the next-largest di…
Disclosed round sizes in Gothenburg skew heavily toward a single outlier: Pagero’s $74M post-IPO debt round on 2022-05-09, which dwarfs the next-largest disclosed amount of $24M (PulPac on 2025-07-03). Below that, several rounds cluster around single-digit or sub-$1M disclosures, with the smallest disclosed amount at $20K (Fluicell on 2024-10-17), creating a wide spread across the most recent 27 rows.
The timing also concentrates. Rounds span 2020-08-20 (Hiber) through 2025-11-04 (DREV), and the most recent year shows multiple seed rounds (e.g., DREV $3M on 2025-11-04; Cetasol $3M on 2025-09-28; Oddbird $1M on 2024-06-12). City specificity is consistent (all 27 rows list Gothenburg, with one “Gothenburg, Vastra Gotaland” form repeating across entries), while stage disclosures are fragmented: “Series Unknown” appears 11 times and “undisclosed” amounts appear 3 times.
Most recent rounds
27 shownRelated listings
Frequently asked
What stands out in round size, and how extreme is the top deal versus the rest?
Pagero’s $74M post-IPO debt round (2022-05-09) is the only disclosed round above $50M. The next-largest disclosed amount is PulPac’s $24M (2025-07-03), so the largest deal is far outside the main cluster of $3M/$1M levels and smaller.
Where do the disclosed amounts bottom out?
The smallest disclosed amount on the page is Fluicell’s $20K (2024-10-17), which is materially below the nearby low-disclosure neighbors such as MucoLife Therapeutics at $30K (2024-09-06) and RadChat at $40K (2023-06-15). Three other entries show “undisclosed” amounts instead of dollar figures.
Is there a recent timing cluster inside the 27 rows?
The listing spans 2020-08-20 (Hiber) to 2025-11-04 (DREV), with a dense run in 2024–2025. Multiple seed rounds fall within that window, including DREV ($3M, 2025-11-04), Cetasol ($3M, 2025-09-28), Adsorbi ($1M, 2025-01-28), and Oddbird ($1M, 2024-06-12).
Do stages or amount disclosures dominate in a way that matters for outreach targeting?
“Series Unknown” accounts for 11 of 27 rows, and it appears across different areas (e.g., PulPac $24M on 2025-07-03; Mecenat marked “undisclosed” on 2024-12-20). “undisclosed” amounts appear 3 times (SMAQO on 2025-09-09; Eneryield on 2024-05-28; Mycorena on 2023-01-25), so dollar-based prioritization is uneven.
Are there sector concentrations, or is the mix too broad to cluster?
The sector mix is broad, but Biotechnology recurs multiple times (Verigraft AB on 2025-02-13, Fluicell on 2024-10-17, Mycorena on 2023-01-25, and MucoLife Therapeutics on 2024-09-06). Health Care also clusters through entries like Adsorbi (2025-01-28), Monivent (2024-10-09), and MucoLife Therapeutics (2024-09-06), with no single sector dominating the full set.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.